Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-16T02:15:58.360Z Has data issue: false hasContentIssue false

Assessing a New Phenothiazine

Published online by Cambridge University Press:  08 February 2018

A. A. Baker
Affiliation:
Banstead Hospital, Sutton, Surrey
J. G. Thorpe
Affiliation:
Banstead Hospital, Sutton, Surrey
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

7044 is a new phenothiazine derivative which can be regarded, pharmacologically, as resembling chlorpromazine much more closely than it does promethazine. It is said to have the characteristic central properties of chlorptomazine more highly developed, and in addition anti-adrenaline properties with anti-histamine properties comparable to those of promethazine. On a theoretical basis it might have the clinical indications of chlorpromazine.

Information

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1958 
Submit a response

eLetters

No eLetters have been published for this article.